Landmark donation from Chan Soon-Shiong Family Foundation establishes pioneering diabetes endowment

 
 
Contact: Tami Dennis
800-888-5323
tdennis@coh.org
 
 
DUARTE, Calif., April 29, 2013 — A $2.5 million commitment from the foundation of Patrick Soon-Shiong, M.D., and his wife, Michele Chan, will be used to create the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes at City of Hope. The pledge, which will be used to enhance the scientific core and capacity of City of Hope’s Diabetes Research Center by recruiting a nationally acclaimed leader in the field of diabetes research, was given in honor of Annette and Leonard Shapiro, longtime friends and supporters of groundbreaking diabetes research and of City of Hope.

“This generous gift from the Chan Soon-Shiong Family Foundation will contribute to City of Hope’s already strong track record in successfully understanding the debilitating problems of diabetes patients,” said Michael A. Friedman, M.D., chief executive officer and Irell & Manella Cancer Center Director’s Distinguished Chair at City of Hope. “Dr. Soon-Shiong began his storied career to improve diabetes care. The fact that the commitment honors the Shapiros, whose family has supported City of Hope for more than half of our institutional history and who were instrumental in helping establish City of Hope’s diabetes program, makes it even more special.”
 
“As a now national leader in diabetes research, with a long legacy of breakthroughs and milestone discoveries, City of Hope is honored to have its work – and the Shapiros’ role – recognized.”
 
Soon-Shiong, a world-renowned surgeon, inventor and philanthropist who developed two leading pharmaceutical companies, and his wife have committed to support City of Hope as part of their foundation’s continuing work to fight diabetes and cancer – transforming the treatment of patients in America. With this pledge, their foundation honors the Shapiros, who themselves have a distinguished legacy of supporting diabetes research at City of Hope.
 
“We offer this donation humbly and in the proud tradition of two dear friends and devoted supporters of diabetes research in America,” remarked Soon-Shiong. “City of Hope has a legacy of improving lives and, indeed, empowering hope for countless individuals who suffer from this debilitating disease. We look forward to supporting this wonderful organization as they continue to make great strides in working toward a cure.” 
 
The Shapiros’ commitment to City of Hope’s diabetes research program accompanied the inception of the program itself. Having had a son with type 1 diabetes, and understanding too well the toll of the disease, the Shapiros launched Founders for Diabetic Research in the early 1970s, helping guarantee the development of the diabetes program as an integral part of City of Hope’s mission. Since then, diabetes research at City of Hope has led to, among other breakthroughs, the discovery of synthetic human insulin.
 
“We don’t look at this merely as a donation, but as a partnership,” noted Soon-Shiong. “This is an investment not merely in what City of Hope has done, but what they WILL do in the years ahead to address the causes and cures of this dreadful disease. With each passing day, we are learning more … and with each passing day, we will stand with and support the bold and brilliant individuals who are devoting their life to this challenging but worthy endeavor.”
 
This latest gift to City of Hope will continue the legacy of diabetes research that the Shapiros helped launch, bringing additional active research to the Diabetes Research Center and aiding in the recruitment and retention of a nationally recognized leader in the field of diabetes research.
 

 
About City of Hope
 
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on Facebook, Twitter, YouTube, Breakthroughs blog or Flickr.